Limited efficacy and tolerance of imatinib mesylate in steroid-refractory sclerodermatous chronic GVHD

被引：29

作者：

de Masson, Adele ^{[1
,2
]}

Bouaziz, Jean-David ^{[1
,2
]}

de Latour, Regis Peffault ^{[3
]}

Wittnebei, Sebastian ^{[4
]}

Ribaud, Patricia ^{[3
]}

Rubio, Marie-Therese ^{[5
]}

Micol, Jean-Baptiste ^{[4
]}

Suarez, Felipe ^{[6
]}

Nguyen, Stephanie ^{[7
]}

Dalle, Jean-Hugues ^{[8
]}

Yakouben, Karima ^{[8
]}

Robin, Marie ^{[3
]}

Xhaard, Alienor ^{[3
]}

Ades, Lionel ^{[3
]}

Bourhis, Jean-Henri ^{[4
]}

Rybojad, Michel ^{[1
,2
]}

Bagot, Martine ^{[1
,2
]}

Socie, Gerard ^{[3
]}

机构：

[1] Univ Paris 07, Hop St Louis, AP HP, Serv Dermatol, F-75010 Paris, France

[2] Univ Paris 07, Hop St Louis, Lab Immunol Dermatol & Oncol, UMR S 976, F-75010 Paris, France

[3] Hop St Louis, Serv Hematol Greffe, Paris, France

[4] Inst Gustave Roussy, Serv Hematol Oncol, Villejuif, France

[5] Hop St Antoine, Serv Hematol & Therapie Cellulaire, F-75571 Paris, France

[6] Hop Necker Enfants Malad, Serv Hematol Adultes, Paris, France

[7] Hop La Pitie Salpetriere, Serv Hematol, Paris, France

[8] Hop Robert Debre, Serv Hematol Immunol Pediat, F-75019 Paris, France

来源：

BLOOD | 2012年 / 120卷 / 25期

关键词：

VERSUS-HOST-DISEASE;

D O I：

10.1182/blood-2012-09-453928

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：5089 / 5090

页数：2

共 6 条

[1] A phase 1 study of imatinib for corticosteroid-dependent/refractory chronic graft-versus-host disease: response does not correlate with anti-PDGFRA antibodies
Chen, George L.
Arai, Sally
Flowers, Mary E. D.
Otani, Joanne M.
Qiu, Jingxin
Cheng, Ethan C.
McMillan, Alex
Johnston, Laura J.
Shizuru, Judith A.
Miklos, David B.
[J]. BLOOD, 2011, 118 (15) : 4070 - 4078
[2] National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report
Filipovich, AH
Weisdorf, D
Pavletic, S
Socie, G
Wingard, JR
Lee, SJ
Martin, P
Chien, J
Przepiorka, D
Couriel, D
Cowen, EW
Dinndorf, P
Farrell, A
Hartzman, R
Henslee-Downey, J
Jacobsohn, D
McDonald, G
Mittleman, B
Rizzo, JD
Robinson, M
Schubert, M
Schultz, K
Shulman, H
Turner, M
Vogelsang, G
Flowers, MED
[J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2005, 11 (12) : 945 - 956
[3] Correlation between NIH composite skin score, patient-reported skin score, and outcome: results from the Chronic GVHD Consortium
Jacobsohn, David A.
Kurland, Brenda F.
Pidala, Joseph
Inamoto, Yoshihiro
Chai, Xiaoyu
Palmer, Jeanne M.
Arai, Sally
Arora, Mukta
Jagasia, Madan
Cutler, Corey
Weisdorf, Daniel
Martin, Paul J.
Pavletic, Steven Z.
Vogelsang, Georgia
Lee, Stephanie J.
Flowers, Mary E. D.
[J]. BLOOD, 2012, 120 (13) : 2545 - 2552
[4] Imatinib mesylate as salvage therapy for refractory sclerotic chronic graft-versus-host disease
Magro, Leonardo
Mohty, Mohamad
Catteau, Benoit
Coiteux, Valerie
Chevallier, Patrice
Terriou, Louis
Jouet, Jean-Pierre
Yakoub-Agha, Ibrahim
[J]. BLOOD, 2009, 114 (03) : 719 - 722
[5] Imatinib for refractory chronic graft-versus-host disease with fibrotic features
Olivieri, Attilio
Locatelli, Franco
Zecca, Marco
Sanna, Adele
Cimminiello, Michele
Raimondi, Roberto
Gini, Guido
Mordini, Nicola
Balduzzi, Adriana
Leoni, Pietro
Gabrielli, Armando
Bacigalupo, Andrea
[J]. BLOOD, 2009, 114 (03) : 709 - 718
[6] Stimulatory autoantibodies to PDGF receptor in patients with extensive chronic graft-versus-host disease
Svegliati, Silvia
Olivieri, Attilio
Campelli, Nadia
Luchetti, Michele
Poloni, Antonella
Trappolini, Silvia
Moroncini, Gianluca
Bacigalupo, Andrea
Leoni, Pietro
Avvedimento, Enrico V.
Gabrielli, Armando
[J]. BLOOD, 2007, 110 (01) : 237 - 241

← 1 →